(Q38457923)

3 September 2017

0 references

Identification of novel therapeutic target genes in acquired lapatinib-resistant breast cancer by integrative meta-analysis (English)

1 reference

3 September 2017

Young Seok Lee

1

1 reference

3 September 2017

Sun Goo Hwang

2

1 reference

3 September 2017

Jin Ki Kim

3

1 reference

3 September 2017

Tae Hwan Park

4

1 reference

3 September 2017

Young Rae Kim

5

1 reference

3 September 2017

Ho Sung Myeong

6

1 reference

3 September 2017

Jong Duck Choi

7

1 reference

3 September 2017

Kang Kwon

8

1 reference

3 September 2017

Cheol Seong Jang

9

1 reference

3 September 2017

Young Tae Ro

10

1 reference

3 September 2017

Yun Hee Noh

11

1 reference

3 September 2017

Sung Young Kim

12

1 reference

3 September 2017

11 September 2015

1 reference

3 September 2017

1 reference

3 September 2017

37

1 reference

3 September 2017

2

1 reference

3 September 2017

2285-2297

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-015-4033-7

3 September 2017

0 references

cites work

Different strategies to overcome multidrug resistance in cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4033-7

Targeting multidrug resistance in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4033-7

Molecular pathways: regulation and therapeutic implications of multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4033-7

Molecular mechanisms of drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4033-7

Evolution of acquired resistance to anti-cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4033-7

Lapatinib: a small-molecule inhibitor of epidermal growth factor receptor and human epidermal growth factor receptor-2 tyrosine kinases used in the treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4033-7

Lapatinib: a dual inhibitor of human epidermal growth factor receptor tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4033-7

The ErbB/HER family of protein-tyrosine kinases and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4033-7

Molecular pathways: resistance to kinase inhibitors and implications for therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4033-7

Acquired resistance to small molecule ErbB2 tyrosine kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4033-7

Acquired resistance to drugs targeting receptor tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4033-7

Identification of novel determinants of resistance to lapatinib in ERBB2-amplified cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4033-7

A systematic review of dual targeting in HER2-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4033-7

Overcoming resistance and restoring sensitivity to HER2-targeted therapies in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4033-7

Key issues in conducting a meta-analysis of gene expression microarray datasets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4033-7

A comprehensive analysis of candidate genes and pathways in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4033-7

The glucose-deprivation network counteracts lapatinib-induced toxicity in resistant ErbB2-positive breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4033-7

Novel mechanism of lapatinib resistance in HER2-positive breast tumor cells: activation of AXL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4033-7

NF-κB activation-induced anti-apoptosis renders HER2-positive cells drug resistant and accelerates tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4033-7

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4033-7

INMEX--a web-based tool for integrative meta-analysis of expression data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4033-7

The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4033-7

Comparative Analysis of Glycogene Expression in Different Mouse Tissues Using RNA-Seq Data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4033-7

Interaction networks of lithium and valproate molecular targets reveal a striking enrichment of apoptosis functional clusters and neurotrophin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4033-7

Detecting overlapping protein complexes in protein-protein interaction networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4033-7

ARACNE: An Algorithm for the Reconstruction of Gene Regulatory Networks in a Mammalian Cellular Context

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4033-7

Key regulators in prostate cancer identified by co-expression module analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4033-7

PTRF/cavin-1 is essential for multidrug resistance in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4033-7

Regulation of the transcriptional coactivator FHL2 licenses activation of the androgen receptor in castrate-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4033-7

Tob genes in development and homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4033-7

TOB suppresses breast cancer tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4033-7

TOB1 is regulated by EGF-dependent HER2 and EGFR signaling, is highly phosphorylated, and indicates poor prognosis in node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4033-7

SOCS2 mediates the cross talk between androgen and growth hormone signaling in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4033-7

Functional networks of nucleocytoplasmic transport-related genes differentiate ischemic and dilated cardiomyopathies. A new therapeutic opportunity

21 January 2018

1 reference

12 December 2020

Galectin-1 is overexpressed in CD133+ human lung adenocarcinoma cells and promotes their growth and invasiveness.

1 reference

12 December 2020

Transcriptional regulation of the tumor suppressor FHL2 by p53 in human kidney and liver cells

1 reference

12 December 2020

Cavin-1/PTRF alters prostate cancer cell-derived extracellular vesicle content and internalization to attenuate extracellular vesicle-mediated osteoclastogenesis and osteoblast proliferation

1 reference

12 December 2020

Identification of potential transcriptomic markers in developing ankylosing spondylitis: a meta-analysis of gene expression profiles

1 reference

12 December 2020

Lapatinib in breast cancer

1 reference

12 December 2020

Transcriptome meta-analysis reveals dysregulated pathways in nasopharyngeal carcinoma

1 reference

12 December 2020

A general framework for weighted gene co-expression network analysis

1 reference

12 December 2020

HER2 breast cancer therapies: a review

1 reference

12 December 2020

Serine protease PRSS23 is upregulated by estrogen receptor α and associated with proliferation of breast cancer cells

1 reference

12 December 2020

Knockdown of galectin-1 suppresses the growth and invasion of osteosarcoma cells through inhibition of the MAPK/ERK pathway

1 reference

12 December 2020

10.1007/S13277-015-4033-7

Identifiers

DOI

1 reference

Dimensions Publication ID

3 September 2017

0 references

1 reference